HayarhiK,HasegawaY,TokoroT.,LimSJ,RohMI,KwonOW,,1986,serous chorioretinopathy: short term Indocyanine green angiography of central effects,Int ophthalmol 347,9,16-41
OPhthalmol Pruntec C.,,1995,Indocyanine green bevacizumab injection for central serous angiographic findings in central serous chorioretinopathy,Int,19,106-82
PruntecC,SmretschnigE,Ansori-shahrezaeiS,,2012,and venous congestion in central serous M o u s s a S , e t a l . H a l f fl u e n e n c e chorioretinopathy,Retina,32,26-34
BurumcekE,MudunA,Kara corulaS,ZhaoMw,ZhovP,XiaoHX,,1997,effective lowest dose of verteporfin,,104,616-622
StangaPE,LimJI,HamiltonP,ChanMW,LaiRY,,2003,one year results of randomized controlled,Ophthalmology,110,15-21
Torres-SorianoME,Garcia-AguirreG,jaraV,,2008,a pilot study of intravitreal 1765. bevacizumab for treatment of central serous retinopathy. Graefes Arch clinic exp,Ophthalmol,246,1235-1239
KarnyangeML,,2002,Delaey jj. Long term follow up of central serous chorioretinopathy,Bull Soc Belgo OPhthalmol,284,39-44
PiccolinoFc,,1994,central serous chorioretinopathy and inndocyanine green angiography,Retina,14,231-242
Mc,,2016,Aqueous humour and plasma level of endothelial growth factor and interlukin-8 in patients with central Serous chorioretinopathy,Retina Submitted for publication: 07.12,30,1464-
SeongHK,BaeJH,KimES,,,2018 vitreous bevacizumab to treat acute central,AAfctceerpRteedvifsoiornpublication: 22.03,,-